Hsin-Fu Lee

6PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 07, 2024
Cardiovascular and venous thromboembolism risks in cancer patients treated with immune checkpoint inhibitors compared to non-users- a multi-center retrospective study.

Jian-Rong Peng, Jason Chia-Hsun Hsieh, Chih-Hao Chang

|Aug 12, 2024
Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium-glucose cotransporter 2 inhibitors users versus non-users. A propensity score matching National Cohort Study.

Tzu-Yang Chen, Hsin-Fu Lee, Yi-Hsin Chan

|May 13, 2024
Clinical Outcomes in Type 2 Diabetes Patients After Acute Myocardial Infarction: A Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs. Non-Users.

Hsin-Fu Lee, Yi-Hsin Chan, Tzyy-Jer Hsu

|Jan 13, 2023
Cardiovascular, renal, and lower limb outcomes in patients with type 2 diabetes after percutaneous coronary intervention and treated with sodium-glucose cotransporter 2 inhibitors vs. dipeptidyl peptidase-4 inhibitors.

Hsin-Fu Lee, Yi-Hsin Chan, Chi Chuang

|May 30, 2018
End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort study.

Hsin-Fu Lee, Lai-Chu See, Yi-Hsin Chan

Pageof 1

Frequent Collaborators

3 joint publications

Lai-Chu See

1 joint publications

Fu-Chih Hsiao

1 joint publications

Tzu-Yang Chen

1 joint publications

Yi-Hsin Chan